The North American Mycoplasma diagnostics market holds a 35.6% share of global markets, according to the World Health Organization (WHO) 2015 data. However, the Asia-Pacific region reported 7.4 million cases of mycoplasma disease in 2016, and this number is expected to rise in the coming years, according to the WHO. Due to the rising number of respiratory tract infections and the rising mortality rate, there are expected to be lucrative opportunities in the Asia Pacific region's mycoplasma diagnostics market. In the upcoming years, key players and the government of this region anticipate greater opportunities in the Asia Pacific regions, which are currently leading the global market.
Read More:
https://knackersblogger.blogspot.com/2022/11/mycoplasma-diagnostics-market-global.html
